GILEAD SCIENCES, INC.
CIK 882095 · last filed 2026-05-27
GILEAD SCIENCES, INC. is a corporate insider who has filed 15 SEC Form 4 insider transactions across 5 companies since 2021. The most recent filing shows the insider was granted $12.5M of ASMB on May 27, 2026. Across all open-market trades the lifetime net is +$628.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.01B across reported positions. The firm reports its address in Foster City, CA. 204 SEC filings were submitted jointly with Gregg H Alton.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.01B
5
15
$628.11M
Filer Profile
FOSTER CITY, CA 94404
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ASMB | 10%+ Owner | 4,977,089 | $30.46 | $151.60M | $20.10M | 4 | 2026-05-27 |
| XLO | 10%+ Owner | 650,389 | $8.93 | $5.81M | $2.20M | 5 | 2026-02-17 |
| RCUS | 10%+ Owner | 31,424,760 | $26.15 | $821.76M | $574.80M | 4 | 2025-02-20 |
| KYTX | 10%+ Owner | 4,126,119 | $7.35 | $30.33M | $20.02M | 1 | 2024-02-13 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | 10%+ Owner | 723,273 | $9.81 | $7.10M | $10.99M | 1 | 2023-06-28 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | ASMB | Grant (A) | +471,698 | $12.50M | EDGAR |
| 2026-02-17 | XLO | Buy (P) | — | $0 | EDGAR |
| 2025-12-01 | XLO | Exer (X) | — | $0 | EDGAR |
| 2025-10-03 | ASMB | Buy (P) | +2,295,920 | $0 | EDGAR |
| 2025-06-06 | XLO | Buy (P) | — | $0 | EDGAR |
| 2025-02-20 | RCUS | Buy (P) | +1,363,636 | $15.00M | EDGAR |
| 2024-12-23 | ASMB | Buy (P) | +940,499 | $20.10M | EDGAR |
| 2024-12-19 | XLO | Buy (P) | +1,759,978 | $1.83M | EDGAR |
| 2024-06-20 | ASMB | Buy (P) | +179,500 | $0 | EDGAR |
| 2024-04-03 | XLO | Buy (P) | +485,250 | $368.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.